Expanded access allows patients to receive innovative new drugs. How often does the FDA approve patients’ requests?

Expanded access allows patients to receive innovative new drugs. How often does the FDA approve patients’ requests?

The FDA’s expanded access program has allowed many desperately ill patients to receive experimental treatments in an effort to save lives. Just last fiscal year, over 1,700 requests were made by patients to access experimental treatments. The Food and Drug Administration’s Center for Drug Evaluation and Research and their Center for Biologics Evaluation and Research combined approved 99.4% of those requests.  http://bit.ly/2f61bvK

Comments

comments

2017-09-27T06:08:43+00:00October 31, 2017|General|